Chronic Inflammatory DiseaseSCORIC-ANCT05613712
Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine
An observational study of Chronic Inflammatory Disease, run by University Hospital, Grenoble at 1 site in France.
Trial summary
Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Chronic Inflammatory Disease
- What is being tested?
- Patients and Referring physician
- How many people
- 229 participants
- Where
- 1 siteFrance
- Study dates
- 11 Feb 2023to 4 May 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The SCORIC population targeted by the patient questionnaire represents all patients followed by the rheumatology department of the CHU Grenoble Alpes, having benefited from a holistic analysis of their disease and their comorbidities. The referring physician population will be generated from the medical records of the patients of the SCORIC cohort.
Who may be able to join
- Patient cohort :
- men and women over 18 years of age
- Informed volunteers who have consented to participate in the study
- have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
- have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
- Cohort of referring physicians :
- volunteers who received informed information and consented to participate in the study
- be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes
Who cannot join
- Patient cohort :
- psychiatric pathologies or history of behavioural disorders
- persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
- persons under guardianship or curatorship
- not affiliated to the social security system
- minors
Show all 10Show fewer
- Refusal to participate by the patient and/or unreturned questionnaire
- Cohort of referring physicians:
- the physician is no longer the patient's referring physician
- refusal of the doctor to participate and/or questionnaire not returned
Trial locations and contacts
1 site in 1 country.
About this study
Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes
Read the detailed description
In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.
- Conditions
- Chronic Inflammatory Disease
- Being tested
- Patients, Referring physician
- Keywords
- rheumatoid arthritis, spondyloarthropathy, spondylarthritis, ankylosing spondylitis, psoriatic arthritis, chronic inflammatory rheumatic diseases, comorbidities, continuity of patient care, patient compliance, adherence, non-adherence
- Medical subject headings
- Arthritis, Rheumatoid, Spondylarthropathies, Spondylarthritis, Spondylitis, Ankylosing, Arthritis, Psoriatic, Patient Compliance
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PatientsOther
Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up
Referring physicianOther
Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes
| Study group | Role | What they receive |
|---|---|---|
| Patients | Patients followed by the rheumatology department of the CHU Grenoble Alpes, constituting the SCORIC group Receives: Other: Patients | |
| Referring physician | Physicians identified as the referring physician for patients in the SCORIC group Receives: Other: Referring physician |
What is being measured
The primary outcome is the main question the study is designed to answer.
Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires
Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes
Measured: 1 day
Secondary outcomes (2)
Elements limiting the good ambulatory follow-up, according to the patients
Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up
Measured: 1 day
Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients
Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Nov 2022
- Study start11 Feb 2023
- Primary completion4 May 2023
- Study completion4 May 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Chronic Inflammatory DiseaseStudies of the same condition, open and under way.
- More trials run by University Hospital, GrenobleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 229 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Grenoble
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Xavier ROMAND, PHD, Principal investigator, CHU Grenoble Alpes
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05613712
- Sponsor's protocol ID
- 38RC22.0355
- Acronym
- SCORIC-A
- Status last verified
- Dec 2025
- First submitted
- 4 Nov 2022
- Last updated
- 29 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Lagadou A, Gastaldi R, Vacher L, Baillet A. Gender influences adhesion to recommendations for optimal comorbidity screening and management of patients with chronic inflammatory rheumatic diseases starting a biological disease-modifying antirheumatic drug. RMD Open. 2024 Nov 11;10(4):e004364. doi: 10.1136/rmdopen-2024-004364. No abstract available.
PubMed 39532462
Study at a glance
From the registry record, last updated by the sponsor on 29 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine
- ClinicalTrials.gov ID
- NCT05613712
- Acronym / sponsor ID
- SCORIC-A / 38RC22.0355
- Conditions
- Chronic Inflammatory Disease
- Keywords
- rheumatoid arthritis, spondyloarthropathy, spondylarthritis, ankylosing spondylitis, psoriatic arthritis, chronic inflammatory rheumatic diseases, comorbidities, continuity of patient care
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 229 participants (actual)
- Lead sponsor
- University Hospital, GrenobleUniversity, hospital or other
- Study start
- 11 Feb 2023 (actual)
- Primary completion
- 4 May 2023 (actual)
- Study completion
- 4 May 2023 (actual)
- First posted
- 14 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes
Detailed description
In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patients | – | Other: PatientsPatients followed by the rheumatology department of the CHU Grenoble Alpes, constituting the SCORIC group |
| Referring physician | – | Other: Referring physicianPhysicians identified as the referring physician for patients in the SCORIC group |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The SCORIC population targeted by the patient questionnaire represents all patients followed by the rheumatology department of the CHU Grenoble Alpes, having benefited from a holistic analysis of their disease and their comorbidities. The referring physician population will be generated from the medical records of the patients of the SCORIC cohort.
Key inclusion criteria (8 listed)
- Patient cohort :
- men and women over 18 years of age
- Informed volunteers who have consented to participate in the study
- have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
- have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
Key exclusion criteria (10 listed)
- Patient cohort :
- psychiatric pathologies or history of behavioural disorders
- persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
- persons under guardianship or curatorship
- not affiliated to the social security system
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PatientsDescription by the patients through the questionnaire of the elements limiting the good ambulatory follow-up | Other | Patients |
| Referring physicianDescription by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes | Other | Referring physician |
Primary outcome
Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires
Time frame: 1 day
Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes
2 secondary outcomes
Elements limiting the good ambulatory follow-up, according to the patients
Time frame: 1 day
Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients
Time frame: 1 day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Dec 2025.
- Results publication: PubMed 39532462Lagadou A, Gastaldi R, Vacher L, Baillet A. Gender influences adhesion to recommendations for optimal comorbidity screening and management of patients with chronic inflammatory rheumatic diseases starting a biological disease-modifying antirheumatic drug. RMD Open. 2024 Nov 11;10(4):e004364. doi: 10.1136/rmdopen-2024-004364. No abstract available.
- Individual participant dataSharing planned: No
Related trials for Chronic Inflammatory Disease
Not yet recruiting
Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)
Acute-on-Chronic Liver Failure (ACLF)
RecruitingPhase 1/2
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Graft vs Host Disease
Not yet recruiting
Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial
Acute-on-Chronic Liver Failure (ACLF)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
RecruitingPhase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Xavier ROMAND, PHD principal investigator
CHU Grenoble Alpes
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Inflammatory Disease, run by University Hospital, Grenoble at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05613712, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2025.